NEK9 and cancer: Notably, one of the targets of miR-520f-3p, NEK9, is implicated in the phosphorylation of ARHGEF2, which, in turn, activates RhoA, promoting enhanced cell motility and facilitating both local and distant cancer cell spread [112].